Stay updated on VTX002 vs Placebo in Active UC Clinical Trial
Sign up to get notified when there's something new on the VTX002 vs Placebo in Active UC Clinical Trial page.

Latest updates to the VTX002 vs Placebo in Active UC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 added; Revision: v3.4.1 removed.SummaryDifference0.0%

- Check19 days agoChange DetectedThe only visible change is the revision label updating from Revision: v3.4.0 to Revision: v3.4.1; the study details content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision banner updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedShow glossary toggle added and minor metadata updates including capitalization fixes and revision tag v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 in the study documents. This is a minor metadata update that does not affect study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded a consolidated Locations section listing CA, FL, GA, IN, LA, MI, OH, OK, SC, and TX and updated to Revision: v3.3.3. Removed individual California Locations, Florida Locations, Georgia Locations, Indiana Locations, Louisiana Locations, Michigan Locations, Ohio Locations, Oklahoma Locations, South Carolina Locations, and Texas Locations (Revision: v3.3.2).SummaryDifference0.7%

Stay in the know with updates to VTX002 vs Placebo in Active UC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VTX002 vs Placebo in Active UC Clinical Trial page.